Low LET Irradiations of Uranyl Sulfate Solutions in the Absence and Presence of Fe⁺² and Fe⁺³ ions

Technical Report · Fri Sep 20 04:00:00 EDT 2019

DOI:https://doi.org/10.2172/1574997· OSTI ID:1574997

Kalensky, Michael ^[1]; Brossard, Thomas ^[1]; Tkac, Peter ^[1]; Quigley, Kevin J. ^[1]; Chemerisov, Sergey D. ^[1]

---

1. Argonne National Laboratory (ANL), Argonne, IL (United States)

Argonne National Laboratory (Argonne) is assisting one of the potential domestic Mo-99 producers, SHINE Medical Technologies, as part of the National Nuclear Security Administration’s (NNSA) Office of Material, Management, and Minimization (M³) program in the development of a domestic Mo-99 production pathway that does not use highly enriched uranium (HEU). The process proposed by SHINE would produce Mo-99 by neutron-induced fission of a low enriched uranium (LEU) solution as uranyl sulfate in a subcritical assembly.

• Research Organization: Argonne National Laboratory (ANL), Argonne, IL (United States)
• Sponsoring Organization: USDOE National Nuclear Security Administration (NNSA), Office of Defense Nuclear Nonproliferation. Office of Material Management and Minimization
• DOE Contract Number: AC02-06CH11357
• OSTI ID: 1574997
• Report Number(s): ANL--19/44; 156599
• Country of Publication: United States
• Language: English

Related Subjects

07 ISOTOPE AND RADIATION SOURCES